MÓDULO

2

Lección 8. Encefalomielitis aguda diseminada y otras encefalopatías autoinmunes
Sara Eichau Madueño

Unidad CSUR de Esclerosis Múltiple. Servicio de Neurología. Hospital Universitario Virgen Macarena. Sevilla

Referencias bibliográficas

  1. Hart MN, Earle KM. Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry. 1975 Jun;38(6):585-91. [Pubmed]
  2. Stonehouse M, Gupte G, Wassmer E, Whitehouse WP. Acute disseminated encephalomyelitis: recognition in the hands of general paediatricians. Arch Dis Child. 2003 Feb;88(2):122-4. [Pubmed]
  3. Young NP, Weinshenker BG, Parisi JE, Scheithauer B, Giannini C, Roemer SF, et al. Perivenous demyelination: association with clinically defined acute disseminated encephalomyelitis and comparison with pathologically confirmed multiple sclerosis. Brain. 2010 Feb;133(Pt 2):333-48. [Pubmed]
  4. Leake JA, Albani S, Kao AS, Senac MO, Billman GF, Nespeca MP, et al. Acute disseminated encephalomyelitis in childhood: epidemiologic, clinical and laboratory features. Pediatr Infect Dis J. 2004 Aug;23(8):756-64. [Pubmed]
  5. Yamaguchi Y, Torisu H, Kira R, Ishizaki Y, Sakai Y, Sanefuji M, et al. A nationwide survey of pediatric acquired demyelinating syndromes in Japan. Neurology. 2016 Nov 8;87(19):2006-15. [Pubmed]
  6. Banwell B, Kennedy J, Sadovnick D, Arnold DL, Magalhaes S, Wambera K, et al. Incidence of acquired demyelination of the CNS in Canadian children. Neurology. 2009 Jan 20;72(3):232-9. [Pubmed]
  7. Bhatt P, Bray L, Raju S, Dapaah-Siakwan F, Patel A, Chaudhari R, et al. Temporal Trends of Pediatric Hospitalizations with Acute Disseminated Encephalomyelitis in the United States: An Analysis from 2006 to 2014 using National Inpatient Sample. J Pediatr. 2019 Mar;206:26-32.e1. [Pubmed]
  8. Garg RK. Acute disseminated encephalomyelitis. Postgrad Med J. 2003 Jan;79(927):11-7. [Pubmed]
  9. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain. 2000 Dec;123 Pt 12:2407-22. [Pubmed]
  10. Murthy SN, Faden HS, Cohen ME, Bakshi R. Acute disseminated encephalomyelitis in children. Pediatrics. 2002 Aug;110(2 Pt 1):e21. [Pubmed]
  11. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology. 2001 May 22;56(10):1308-12. [Pubmed]
  12. Tenembaum S, Chitnis T, Ness J, Hahn JS; International Pediatric MS Study Group. Acute disseminated encephalomyelitis. Neurology. 2007 Apr 17;68(16 Suppl 2):S23-36. [Pubmed]
  13. Brass SD, Caramanos Z, Santos C, Dilenge ME, Lapierre Y, Rosenblatt B. Multiple sclerosis vs acute disseminated encephalomyelitis in childhood. Pediatr Neurol. 2003 Sep;29(3):227-31. [Pubmed]
  14. Davis LE, Booss J. Acute disseminated encephalomyelitis in children: a changing picture. Pediatr Infect Dis J. 2003 Sep;22(9):829-31. [Pubmed]
  15. Seales D, Greer M. Acute hemorrhagic leukoencephalitis. A successful recovery. Arch Neurol. 1991 Oct;48(10):1086-8. [Pubmed]
  16. Klein CJ, Wijdicks EF, Earnest F 4th. Full recovery after acute hemorrhagic leukoencephalitis (Hurst's disease). J Neurol. 2000 Dec;247(12):977-9. [Pubmed]
  17. Rosman NP, Gottlieb SM, Bernstein CA. Acute hemorrhagic leukoencephalitis: recovery and reversal of magnetic resonance imaging findings in a child. J Child Neurol. 1997 Oct;12(7):448-54. [Pubmed]
  18. Waak M, Malone S, Sinclair K, Phillips G, Bandodkar S, Wienholt L, et al. Acute Hemorrhagic Leukoencephalopathy: Pathological Features and Cerebrospinal Fluid Cytokine Profiles. Pediatr Neurol. 2019 Nov;100:92-96. [Pubmed]
  19. Ketelslegers IA, Visser IE, Neuteboom RF, Boon M, Catsman-Berrevoets CE, Hintzen RQ. Disease course and outcome of acute disseminated encephalomyelitis is more severe in adults than in children. Mult Scler. 2011 Apr;17(4):441-8. [Pubmed]
  20. Koelman DL, Chahin S, Mar SS, Venkatesan A, Hoganson GM, Yeshokumar AK, et al. Acute disseminated encephalomyelitis in 228 patients: a retrospective, multicenter US study. Neurology. 2016 May 31;86(22):2085-93. [Pubmed]
  21. Marchioni E, Ravaglia S, Piccolo G, Furione M, Zardini E, Franciotta D, et al. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology. 2005 Oct 11;65(7):1057-65. [Pubmed]
  22. Marchioni E, Ravaglia S, Montomoli C, Tavazzi E, Minoli L, Baldanti F, et al. Postinfectious neurologic syndromes: a prospective cohort study. Neurology. 2013 Mar 5;80(10):882-9. [Pubmed]
  23. Callen DJ, Shroff MM, Branson HM, Li DK, Lotze T, Stephens D, Banwell BL. Role of MRI in the differentiation of ADEM from MS in children. Neurology. 2009 Mar 17;72(11):968-73. [Pubmed]
  24. Verhey LH, Branson HM, Shroff MM, Callen DJ, Sled JG, Narayanan S, et al.; Canadian Pediatric Demyelinating Disease Network. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Lancet Neurol. 2011 Dec;10(12):1065-73. [Pubmed]
  25. Mader I, Wolff M, Niemann G, Küker W. Acute haemorrhagic encephalomyelitis (AHEM): MRI findings. Neuropediatrics. 2004 Apr;35(2):143-6. [Pubmed]
  26. Balasubramanya KS, Kovoor JM, Jayakumar PN, Ravishankar S, Kamble RB, Panicker J, Nagaraja D. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology. 2007 Feb;49(2):177-83. doi: 10.1007/s00234-006-0164-2. [Pubmed]
  27. Sonneville R, Demeret S, Klein I, Bouadma L, Mourvillier B, Audibert J, et al. Acute disseminated encephalomyelitisin the intensive care unit:clinical features and outcome of 20 adults. Intensive Care Med. 2008 Mar;34(3):528-32. [Pubmed]
  28. Ramanathan S, Dale RC, Brilot F. Anti-MOG antibody: The history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination. Autoimmun Rev. 2016 Apr;15(4):307-24. [Pubmed]
  29. Krupp LB, Banwell B, Tenembaum S; International Pediatric MS Study Group. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007 Apr 17;68(16 Suppl 2):S7-12. [Pubmed]
  30. Krupp LB, Tardieu M, Amato MP, Banwell B, Chitnis T, Dale RC, et al.; International Pediatric Multiple Sclerosis Study Group. International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult Scler. 2013 Sep;19(10):1261-7. [Pubmed]
  31. De Seze J, Debouverie M, Zephir H, Lebrun C, Blanc F, Bourg V, et al. Acute fulminant demyelinating disease: a descriptive study of 60 patients. Arch Neurol. 2007 Oct;64(10):1426-32. [Pubmed]
  32. Alper G. Acute disseminated encephalomyelitis. J Child Neurol. 2012 Nov;27(11):1408-25. [Pubmed]
  33. Gray MP, Gorelick MH. Acute Disseminated Encephalomyelitis. Pediatr Emerg Care. 2016 Jun;32(6):395-400. [Pubmed]
  34. Iype M, Ts A, Kunju PM, Saradakutty G, Sreedharan M, Ahamed SM. Factors Related to Long Term Motor, Behavioral, and Scholastic Outcome in Children with Acute Disseminated Encephalomyelitis. Pediatr Neurol. 2018 Dec;89:49-57. [Pubmed]
  35. Khong PL, Ho HK, Cheng PW, Wong VC, Goh W, Chan FL. Childhood acute disseminated encephalomyelitis: the role of brain and spinal cord MRI. Pediatr Radiol. 2002 Jan;32(1):59-66. [Pubmed]
  36. Schwarz S, Mohr A, Knauth M, Wildemann B, Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology. 2001 May 22;56(10):1313-8. [Pubmed]
  37. Höllinger P, Sturzenegger M, Mathis J, Schroth G, Hess CW. Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF, EEG, and MRI findings. J Neurol. 2002 Mar;249(3):320-9. [Pubmed]
  38. Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000 Jul;123(Pt 7):1481-94. [Pubmed]
  39. Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003 Nov;78(11):1363-8. [Pubmed]
  40. Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol. 2008 May-Jun;10(3):131-7. [Pubmed]
  41. Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain. 1997 Jun;120(Pt 6):923-8. [Pubmed]
  42. Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu--associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore). 1992 Mar;71(2):59-72. [Pubmed]
  43. Henson RA, Hoffman HL, Urich H. Encephalomyelitis with carcinoma. Brain. 1965 Sep;88(3):449-64. [Pubmed]
  44. Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016 Apr;15(4):391-404. [Pubmed]
  45. Schmitt SE, Pargeon K, Frechette ES, Hirsch LJ, Dalmau J, Friedman D. Extreme delta brush: a unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology. 2012 Sep 11;79(11):1094-100. [Pubmed]
  46. Prüss H, Dalmau J, Harms L, Höltje M, Ahnert-Hilger G, Borowski K, et al. Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin. Neurology. 2010 Nov 9;75(19):1735-9. [Pubmed]
  47. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013 Feb;12(2):157-65. [Pubmed]
  48. Armangue T, Spatola M, Vlagea A, Mattozzi S, Cárceles-Cordon M, Martínez-Heras E, et al.; Spanish Herpes Simplex Encephalitis Study Group. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018 Sep;17(9):760-72. [Pubmed]
  49. Graus F, Vogrig A, Muñiz-Castrillo S, Antoine JG, Desestret V, Dubey D, et al. Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes. Neurol Neuroimmunol Neuroinflamm. 2021 May 18;8(4):e1014. [Pubmed]
  50. Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, et al.; Autoimmune Encephalitis Alliance Clinicians Network. Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry. 2021 Jul;92(7):757-68. [Pubmed]
  51. Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014 Feb;13(2):167-77. Erratum in: Lancet Neurol. 2014 Feb;13(2):135. [Pubmed]
  52. Titulaer MJ, McCracken L, Gabilondo I, Armangué T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013 Feb;12(2):157-65. [Pubmed]